Limited Intra-Individual Variability in Hypoxanthine-Guanine Phosphoribosyl Transferase, Thiopurine S-Methyl Transferase, and Xanthine Oxidase Activity in Inflammatory Bowel Disease Patients During 6-Thioguanine Therapy

6-Thioguanine (6-TG) may be indicated in case of intolerance of or resistance to conventional thiopurines in the treatment of inflammatory bowel diseases (IBD). The aim of our study was to evaluate the intrapatient variability in the 6-TG metabolizing enzymes: hypoxanthine-guanine phosphoribosyl transferase (HGPRT), thiopurine S-methyl transferase and xanthine oxidase. We performed a pharmacokinetic study of 6-TG after oral and intravenous administration in IBD patients in remission. The enzyme activities were determined at baseline and 1 week after the initiation of 6-TG in red blood cells, peripheral blood mononuclear cells (PBMC) or plasma. From the results we conclude that HGPRT activity in erythrocytes decreases following the initiation of 6-TG therapy, which may imply that HGPRT is a rate limiting enzyme in 6-TG metabolism. Moreover, little intrapatient variability in enzyme activities was observed except for HGPRT activity in PBMC. These data may have implications in regard of future therapeutic drug monitoring.

[1]  M. Daperno,et al.  Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease , 2009, Alimentary pharmacology & therapeutics.

[2]  U. Fuhr,et al.  Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected? , 2009, European Journal of Clinical Pharmacology.

[3]  H. Herfarth,et al.  Monitoring of Thiopurine Methyltransferase Activity in Postsurgical Patients With Crohn's Disease During 1 Year of Treatment With Azathioprine or Mesalazine , 2007, Therapeutic drug monitoring.

[4]  A. Timmer,et al.  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. , 2007, The Cochrane database of systematic reviews.

[5]  D. Hommes,et al.  Pharmacokinetics of 6-Thioguanine in Patients With Inflammatory Bowel Disease , 2006, Therapeutic drug monitoring.

[6]  Michel Eichelbaum,et al.  Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. , 2004, Pharmacogenetics.

[7]  R. D. De Abreu,et al.  Measurement of thiopurine S-methyltransferase activity in human blood samples based on high-performance liquid chromatography: reference values in erythrocytes from children , 2003, Annals of clinical biochemistry.

[8]  G. Fick,et al.  Azathioprine for maintaining remission of Crohn's disease. , 1998, The Cochrane database of systematic reviews.

[9]  Ching-Hon Pui,et al.  Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance , 1997, Annals of Internal Medicine.

[10]  A. Spigelman,et al.  Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis. , 1995, Gut.

[11]  R. Weinshilboum,et al.  Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6‐thioguanine nucleotide concentrations , 1987, Clinical pharmacology and therapeutics.

[12]  G. Peters,et al.  Purine and pyrimidine metabolism in peripheral blood lymphocytes. , 1983, The International journal of biochemistry.

[13]  G. Peters,et al.  Concentration, synthesis and utilization of phosphoribosylpyrophosphate in lymphocytes of five mammalian species. , 1979, The International journal of biochemistry.

[14]  T. Hovi,et al.  Purine reutilization in phytohemagglutinin-stimulated human T-lymphocytes. , 1978, Experimental cell research.

[15]  J. Trijbels,et al.  Activity of purine phosphoribosyltransferases and of two enzymes of pyrimidine biosynthesis in erythrocytes of ten mammalian species. , 1976, Comparative biochemistry and physiology. B, Comparative biochemistry.